News
About one in six men with grade group 1 prostate cancer have higher-risk disease, showing outcomes vary and biopsy grade may ...
Keytruda and Padcev generated promising topline results for those with muscle-invasive bladder cancer who are ineligible for ...
Dr. Aaron Gerds explained when treatment with rusfertide will become accessible for patients with a myeloproliferative neoplasm like polycythemia vera.
I’m a testicular cancer survivor diagnosed at 20. My story is about finding strength, building routines, and sharing hope for ...
CURE TV® is a production of countless expert interviews and interactive videos to help guide patients with cancer through all stages of the cancer continuum.
A nurse with metastatic breast cancer praised biology-guided radiation for her slow-growing squamous cell cancer and the team's thoughtful care.
Among Janus kinase (JAK) inhibitor-naïve patients with myelofibrosis, treatment with the combination of pelabresib and ...
Childhood cancer treatments can accelerate biological aging which increases survivors’ risk for long-term health issues like ...
I was facing rare mesothelioma alone at 21 years old, but sharing my story connected me to a community that offers hope and ...
The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, ...
A diverticulitis concern led to a prostate cancer diagnosis that shifted a patient's mindset and highlighted the importance ...
Panelists discuss City of Hope’s collaborative partnership with community physicians, emphasizing expert evaluation at specialized centers while enabling ongoing treatment closer to home for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results